Long-term treatment and suicidal behavior in severe depression: ECT and antidepressant pharmacotherapy may have different effects on the occurrence and seriousness of suicide attempts

Depression and Anxiety

Volumn 23, Issue 1, 2006, Pages 34-41

  Brådvik, Louise ^a   Berglund, Mats ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antidepressants; ECT; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYMPTOMATOLOGY; SYNDROME DELINEATION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION SCHEDULE; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RECURRENCE; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED;

EID: 33644557393     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.20134     Document Type: Article

References (39)

1. Ahrens B, Linden M. 1996. Is there a suicidality syndrome independent of specific major depressive disorder?: Results of a split half multiple regression analysis. Acta Psychiatr Scand 94:79-86.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author.
3. Åsberg M, Nordström P, Träskman-Bendz L. 1986. Cerebrospinal fluid studies in suicide: An overview. Ann NY Acad Sci 487:243-255.
4. Avery D, Winokur G. 1978. Suicide, attempted suicide, and relapse rates in depression: Occurrence after ECT and antidepressant therapy. Arch Gen Psychiatry 35:749-753.
5. Baldessarini RJ, Tondo L, Hennen J. 2003. Lithium treatment and suicide risk in major affective disorders: Update and new findings. J Clin Psychiatry 64(Suppl 5):44-52.
6. Barber ME, Marzuk PM, Leon AC, Portera L. 1998. Aborted suicide attempts: A new classification of suicidal behavior. Am J Psychiatry 155:385-389.
7. Beasley Jr CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN. 1991. Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression. Br Med J 303:685-692.
8. Berglund M, Nilsson K. 1987. Mortality in severe depression: A prospective study including 103 suicides. Acta Psychiatr Scand 76:372-380.
9. Bourgon LN, Kellner CH. 2000. Relapse of depression after ECT: A review. J ECT 16:419-431.
10. Brådvik L, Berglund M. 1993. Risk factors for suicide in melancholia: A case record evaluation of 89 suicides and their controls. Acta Psychiatr Scand 87:306-311.
11. Bradvik L, Berglund M. 2000. Treatment and suicide in severe depression A case-control study on antidepressant treatment at last contact before suicide. J ECT 16:399-408.
12. Brådvik L, Berglund M. 2001. Late mortality in severe depression. Acta Psychiatr Scand 103:111-116.
13. Brådvik L, Berglund M. 2002. Aspects on the suicidal career in severe depression. Arch Suicide Res 6:339-349.
14. Brådvik L, Berglund M. 2005. Suicide in severe depression related to treatment: Depressive characteristics and rate of anti-depressant overdose. Eur Arch Psychiatry Clin Neurosci 255:245-250.
15. Demyttenaere K. 2003. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 13(Suppl 3): S69-S75.
16. Essen-Möller E, Wohlfart S. 1947. Suggestion for the amendment of the official Swedish classification of mental disorders. Psychol Med 1:308-311.
17. Flood RA, Seager CP. 1968. A retrospective examination of psychiatric case records of patients who subsequently committed suicide. Br J Psychiatry 114:443-450.
18. Goldstein RB, Black DW, Nasrallah A, Winokur G. 1991. The prediction of suicide: Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Arch Gen Psychiatry 48:418-422.
19. Jick H, Kaye JA, Jick SS. 2004. Antidepressants and the risk of suicidal behaviours. JAMA 292:379-381.
20. Khan A, Heather A, Warner MA, Brown WA. 2000. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the food and drug administration database. Arch Gen Psychiatry 57:311-317.
21. Khan A, Khan S, Kolts R, Brown WA. 2003. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry 160:790-792.
22. Khan A, Khan SR, Leventahl RM, Brown WA. 2001. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: A replication analysis of the Food and Drug Administration Database. Int J Neuropsychopharm 4:113-118.
23. Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, Endicott J. 1999. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiatry 156:195-201.
24. Lönnqvist JK. 2000. Psychiatric aspects of suicidal behaviour: Depression. In: Hawton K, Van Heeringen K, editors. The international handbook of suicide and attempted suicide. Chichester, UK: Wiley; p 107-120.
25. Mann JJ, Waternaux C, Haas GL, Malone KM. 1999. Toward a clinical model of suicidal behaviour in psychiatric patients. Am J Psychiatry 156:181-189.
26. Marzuk PM, Tardiff K, Leon AC, Portera L, Weiner C. 1997. The prevalence of aborted suicide attempts among psychiatric inpatients. Acta Psychiatr Scand 96:492-496.
27. Mequies L, Jasson M, Soubrie C, Puech AJ. 1998. Suicide prevention: The role of antidepressants. In: Briley M, Montgomery S, editors. Antidepressant therapy at the dawn of the third millennium. London: Martin Dunitz, Ltd. p 307-317.
28. Montgomery SA, Dunner DL, Dunbar GC. 1995. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropharmacol 5:5-13.
29. Nordström P, Samuelsson M, Asberg M, Träskman-Bendz L, Åberg-Wistedt A, Nordin C, Bertilsson L. 1994. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24:1-9.
30. Potter WZ, Rudorfer MV, Manji H. 1991. The pharmacologic treatment of depression. New Engl J Med 325:633-642.
31. Rasmussen KG. 2003. Clinical applications of recent research on electroconvulsive therapy. Bull Menninger Clin 67:18-31.
32. Roullion F, Phillips R, Serruier D, Ansaart E, Gérard M J. 1989. Rechutes de dépression unipolaire et efficacité de la maprotiline [Recurrence of unipolar depression and efficacy of maprotiline]. Encéphale 15:527-534.
33. Sainsbury P. 1986. Depression, suicide and suicide prevention. In: Roy A, editor. Suicide. Baltimore: Williams & Wilkins. p 73-88.
34. Sharma V. 1999. Retrospective controlled study of in-patient ECT Does it prevent suicide? J Affect Disord 56:183-187.
35. Sharma V. 2001. The effect of electroconvulsive therapy on suicide risk in patients with mood disorders. Can J Psychiatry 46:704-709.
36. Spitzer R, Endicott J, Robins E. 1978. Research diagnostic criteria. Arch Gen Psychiatry 5:773-782.
37. Storosum JG, Zwieten BJ, Van Den Brink W, Gersons BPR, Broemans AW. 2001. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158:1271-1275.
38. Tollefsen GD, Fawcett J, Winokur G, Beasley Jr CM, Potvin JH, Faries DE, Rampey Jr AH, Sayler ME. 1993. Evaluation of suicidality during pharmacologic treatment of mood and non-mood disorder. Ann Clin Psychiatry 5:209-224.
39. Yerevanain BI, Kock RJ, Feusner JD, Hwang S, Mintz J. 2004. Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr Scand 110:452-458.